Please Answer this question:

Provide an Financial ratio analysis: liquidity ratios, asset management ratios, debt management ratios, profitability ratios

Net income Other comprehensive income/(loss): Change in foreign currency translation, net of tax Change in unrealized gains/losses on marketable debt securities, net of tax: \begin{tabular}{cc} September 26, September 28, \\ 2020 & 2019 \\ \hline \end{tabular} ASSETS: Current assets: Cash and cash equivalents Marketable securities Accounts receivable, net Inventories Vendor non-trade receivables Other current assets Total current assets 143,71311,264162,81912,362 Non-current assets: LIABILITIES AND SHAREHOLDERS' EQUITY: Current liabities: Non-current liabilities: Term debt Other non-current labilies Total non-current liabilities Total lab Ties \begin{tabular}{rr} 98,667 & 91,807 \\ 54,490 & 50,503 \\ \hline 153,157 & 142,310 \\ \hline 258,549 & 248,02B \\ \hline \end{tabular} Commitments and contingencies Shareholders' ecquity: Common stock and additional paid-in capital, \$0.00001 par value: 50,400,000 shares authorized; 16,976,763 and 17,772,945 shares issued and cutstanding, respectively Retained earnings Accumulated other comprehensive income(loss) Total shareholders" equity Total labities and shareholders' equity Net income Other comprehensive income/(loss): Change in foreign currency translation, net of tax Change in unrealized gains/losses on marketable debt securities, net of tax: \begin{tabular}{cc} September 26, September 28, \\ 2020 & 2019 \\ \hline \end{tabular} ASSETS: Current assets: Cash and cash equivalents Marketable securities Accounts receivable, net Inventories Vendor non-trade receivables Other current assets Total current assets 143,71311,264162,81912,362 Non-current assets: LIABILITIES AND SHAREHOLDERS' EQUITY: Current liabities: Non-current liabilities: Term debt Other non-current labilies Total non-current liabilities Total lab Ties \begin{tabular}{rr} 98,667 & 91,807 \\ 54,490 & 50,503 \\ \hline 153,157 & 142,310 \\ \hline 258,549 & 248,02B \\ \hline \end{tabular} Commitments and contingencies Shareholders' ecquity: Common stock and additional paid-in capital, \$0.00001 par value: 50,400,000 shares authorized; 16,976,763 and 17,772,945 shares issued and cutstanding, respectively Retained earnings Accumulated other comprehensive income(loss) Total shareholders" equity Total labities and shareholders' equity